JOBEVNE vs LUMAKRAS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 12, 2026·How we rate

Possible drug interaction. JOBEVNE and LUMAKRAS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	JOBEVNE	LUMAKRAS
Rating	New	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	BEVACIZUMAB-NWGD	SOTORASIB
Manufacturer	Biocon Biologics Inc	Amgen Inc
Dosage forms	Injectable	Tablet
Drug class	—	—
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms	Non-Small-Cell Lung Carcinoma

jobevne lumakras

Rating

New

72/100

Pharmacy pays

—

Type

Active ingredient

BEVACIZUMAB-NWGD

SOTORASIB

Manufacturer

Biocon Biologics Inc

Amgen Inc

Dosage forms

Injectable

Tablet

Drug class

—

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms

Non-Small-Cell Lung Carcinoma

Frequently asked questions

What is the difference between Jobevne and Lumakras?

Jobevne contains Bevacizumab-Nwgd, while Lumakras contains Sotorasib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.